Sutro Biopharma Inc (STRO)
$3.47
Sutro Biopharma Inc (STRO) Share Price Forecast
Currently 15 wall-street analysts regularly analyze the financials of Sutro Biopharma Inc on a frequent basis to provide recommendations along with target share price. 15 analysts offering 12-month price forecasts for Sutro Biopharma Inc (STRO) have a share price target of $17.75. This median of share price forecast represents a 411.53% upside from the latest price of $3.47 as on 01.10.23.
Sutro Biopharma Inc (STRO) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Sutro Biopharma Inc (STRO) share price will touch around $17.75 in next 12-months.
Sutro Biopharma Inc (STRO) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Sutro Biopharma Inc's share price and its median forecast price. As on 01.10.23, the difference is -74.65%
Sutro Biopharma Inc (STRO): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Sutro Biopharma Inc (STRO) Share Price : Analyst Recommendation
Based on 15 analysts tracking and researching Sutro Biopharma Inc (STRO) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 9 | 9 | 9 |
| Outperform | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Sutro Biopharma Inc (STRO) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Sutro Biopharma Inc (STRO) is $17.75, offered by 15 analysts offering 12-month price forecasts.
Sutro Biopharma Inc (STRO) has a maximum of 4.12 upside potential, based on 15 analysts offering 12-month price forecasts.
Based on 15 analysts tracking and researching Sutro Biopharma Inc (STRO), 86.67% have a buy recommendation. Remaining 13.33% have either sell or hold recommendations.
The latest share price of Sutro Biopharma Inc (STRO) is $3.47 as of 01/10/2023.
13 of total 15 analysts offering stock ratings for Sutro Biopharma Inc STRO have recommended buy rating.
₹0 US Stocks a/c Opening Fee